OTC Markets OTCPK - Delayed Quote USD
Camurus AB (publ) (CAMRF)
At close: November 18 at 3:00 PM EST
Research Analysis
Revenue vs. Earnings
Revenue 479.6M
Earnings 129.35M
Q4'23
Q1'24
Q2'24
Q3'24
0
100M
200M
300M
400M
Analyst Price Targets
No Analyst Price Targets available for this ticker
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 5 | 6 |
| Avg. Estimate | 531.83M | 611M | 1.85B | 2.92B |
| Low Estimate | 518M | 611M | 1.83B | 2.7B |
| High Estimate | 542M | 611M | 1.86B | 3.42B |
| Year Ago Sales | 374.57M | 389.99M | 1.72B | 1.85B |
| Sales Growth (year/est) | 41.99% | 56.67% | 7.88% | 57.46% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -- | -- | -- | -- |
| 7 Days Ago | -- | -- | -- | -- |
| 30 Days Ago | -- | -- | -- | -- |
| 60 Days Ago | -- | -- | -- | -- |
| 90 Days Ago | -- | -- | -- | -- |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CAMRF | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.00% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | -- | -- | -- | 2.10% |
| Next Year | -- | -- | -- | 12.20% |
Related Tickers
CR5.F Oculis Holding AG
11.00
0.00%
CKDXF Opthea Limited
0.4400
0.00%
CMVLF Cellectis S.A.
2.5400
0.00%
BIX0.DU BioInvent International AB
4.0250
0.00%
CLYYF Celyad Oncology SA
0.2450
0.00%
DBVTF DBV TECHNOLOGIES
0.7859
0.00%
CYYNF Cynata Therapeutics Limited
0.1900
0.00%
CFRXQ ContraFect Corporation
0.0001
0.00%
CPMV Mosaic ImmunoEngineering, Inc.
0.9900
0.00%
BXRXQ Baudax Bio, Inc.
0.0001
0.00%